title: Current status of human papillomavirus vaccination implementation in central and eastern Europe.
abstract: We present a review of the current implementation status of vaccination against human papillomaviruses (HPV) and available data concerning the burden of HPV infection and HPV type-specific distribution in 16 central and eastern European countries: Albania, Bosnia and Herzegovina, Bulgaria, Croatia, the Czech Republic, Estonia, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia, and The Former Yugoslav Republic of Macedonia. At least one current HPV prophylactic vaccine is registered in all central and eastern European countries except Montenegro. Six counties-Bulgaria, the Czech Republic, Latvia, Romania, Slovenia, and Former Yugoslav Republic of Macedonia-have integrated the HPV vaccination into their national immunization program and currently provide routine vaccination free of charge to the primary target population. Ten countries have not integrated HPV vaccination into the national immunization program. The key reasons for lack of implementation of HPV vaccination into the national immunization program are the high vaccine cost and negative public perception. Vaccination of males is not recommended in any country in the region.
authors.affiliation: Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
authors.forename: Katja
authors.initials: K
authors.lastname: Seme
authors.forename: Polona J
authors.initials: PJ
authors.lastname: Maver
authors.forename: Tina
authors.initials: T
authors.lastname: Korać
authors.forename: Amalia
authors.initials: A
authors.lastname: Canton
authors.forename: Jitka
authors.initials: J
authors.lastname: Částková
authors.forename: Goran
authors.initials: G
authors.lastname: Dimitrov
authors.forename: Irina
authors.initials: I
authors.lastname: Filippova
authors.forename: Helena
authors.initials: H
authors.lastname: Hudecová
authors.forename: Ermina
authors.initials: E
authors.lastname: Iljazović
authors.forename: Bernard
authors.initials: B
authors.lastname: Kaić
authors.forename: Vesna
authors.initials: V
authors.lastname: Kesić
authors.forename: Nerija
authors.initials: N
authors.lastname: Kuprevičienė
authors.forename: Dragan
authors.initials: D
authors.lastname: Laušević
authors.forename: Zsuzsanna
authors.initials: Z
authors.lastname: Molnár
authors.forename: Jurijs
authors.initials: J
authors.lastname: Perevoščikovs
authors.forename: Marek
authors.initials: M
authors.lastname: Spaczyński
authors.forename: Venera
authors.initials: V
authors.lastname: Stefanova
authors.forename: Veronika
authors.initials: V
authors.lastname: Učakar
authors.forename: Mario
authors.initials: M
authors.lastname: Poljak
mesh_terms: D002648:Child; D003625:Data Collection; D005061:Europe, Eastern; D005260:Female; D006801:Humans; D008297:Male; D009313:National Health Programs; D053918:Papillomavirus Vaccines; D014611:Vaccination / Q000706:statistics & numerical data
chemical_list: D053918:Papillomavirus Vaccines